Primary Endocrine Therapy for Locally Advanced Breast Cancer-Is it an Inferior Approach? Experience from Nottingham.
作者信息
Lakshmanan Radhika, Cheung Kwok Leung
出版信息
Indian J Surg Oncol. 2010 Sep;1(3):224-7. doi: 10.1007/s13193-010-0035-5. Epub 2010 Dec 30.
Abstract
Treatment strategy for locally advanced primary breast cancer(LAPC) remains mainly multimodal involving neoadjuvant chemotherapy, surgery followed by radiotherapy and endocrine therapy, all given upfront. There have been few studies comparing this with a sequential treatment approach, for instance, using endocrine therapy as initial treatment. Based on small randomised clinical trials and local experience in Nottingham, primary endocrine therapy has been shown to produce very good early (response) and late (survival) outcome when used in ER positive, noninflammatory LAPC. This could be considered as a viable therapeutic option in appropriately selected patients.
摘要
相似文献
1
Primary Endocrine Therapy for Locally Advanced Breast Cancer-Is it an Inferior Approach? Experience from Nottingham.
Indian J Surg Oncol. 2010 Sep;1(3):224-7. doi: 10.1007/s13193-010-0035-5. Epub 2010 Dec 30.
2
Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.局部晚期乳腺癌的原发性内分泌治疗——诺丁汉经验
Breast Cancer Res Treat. 2009 Jan;113(2):403-7. doi: 10.1007/s10549-008-9930-7. Epub 2008 Mar 2.
3
Association of Modified-FOLFIRINOX-Regimen-Based Neoadjuvant Therapy with Outcomes of Locally Advanced Pancreatic Cancer in Chinese Population.改良 FOLFIRINOX 方案新辅助治疗与中国局部晚期胰腺癌患者结局的相关性。
Oncologist. 2019 Mar;24(3):301-e93. doi: 10.1634/theoncologist.2018-0696. Epub 2018 Nov 20.
4
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.局部晚期原发性乳腺癌的新辅助化疗：诺丁汉经验
Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27.
5
Possibility of conservative local treatment after combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer.局部晚期非炎性乳腺癌联合化疗及术前放疗后进行保守局部治疗的可能性
Int J Radiat Oncol Biol Phys. 1996 Mar 15;34(5):1019-28. doi: 10.1016/0360-3016(95)02207-4.
6
Treatment of breast cancer in countries with limited resources.资源有限国家的乳腺癌治疗
Breast J. 2003 May-Jun;9 Suppl 2:S67-74. doi: 10.1046/j.1524-4741.9.s2.6.x.
7
8
Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?在新辅助治疗中使用芳香化酶抑制剂：是演进还是变革？
Cancer Treat Rev. 2005 Feb;31(1):1-17. doi: 10.1016/j.ctrv.2004.09.008. Epub 2004 Nov 18.
9
Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort.曲妥珠单抗新辅助和辅助治疗人表皮生长因子受体 2 阳性局部晚期乳腺癌（NOAH）患者：一项随机对照优效试验的随访，该试验具有平行的人表皮生长因子受体 2 阴性队列。
Lancet Oncol. 2014 May;15(6):640-7. doi: 10.1016/S1470-2045(14)70080-4. Epub 2014 Mar 20.
10
Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study.紫杉醇和表柔比星新辅助治疗浸润性乳腺癌：一项II期研究。
Clin Drug Investig. 2006;26(12):691-701. doi: 10.2165/00044011-200626120-00003.
本文引用的文献
1
Primary endocrine therapy in locally advanced breast cancers--the Nottingham experience.局部晚期乳腺癌的原发性内分泌治疗——诺丁汉经验
Breast Cancer Res Treat. 2009 Jan;113(2):403-7. doi: 10.1007/s10549-008-9930-7. Epub 2008 Mar 2.
2
CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY.乳腺癌：II. 可手术性标准。
Ann Surg. 1943 Nov;118(5):859-70. doi: 10.1097/00000658-194311850-00008.
3
Neoadjuvant chemotherapy in locally advanced primary breast cancers: the Nottingham experience.局部晚期原发性乳腺癌的新辅助化疗：诺丁汉经验
Eur J Surg Oncol. 2007 Oct;33(8):972-6. doi: 10.1016/j.ejso.2007.02.005. Epub 2007 Mar 27.
4
Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18.可手术乳腺癌患者的术前化疗：国家外科辅助乳腺和肠道项目B-18的九年结果
J Natl Cancer Inst Monogr. 2001(30):96-102. doi: 10.1093/oxfordjournals.jncimonographs.a003469.
5
Locally advanced primary breast cancer: medium-term results of a randomised trial of multimodal therapy versus initial hormone therapy.局部晚期原发性乳腺癌：多模式治疗与初始激素治疗随机试验的中期结果
Eur J Cancer. 2001 Dec;37(18):2331-8. doi: 10.1016/s0959-8049(01)00298-2.
6
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.原发性可手术乳腺癌的术前化疗：欧洲癌症研究与治疗组织试验10902的结果
J Clin Oncol. 2001 Nov 15;19(22):4224-37. doi: 10.1200/JCO.2001.19.22.4224.
7
Locally advanced breast cancer: long-term results of a randomized trial comparing primary treatment with tamoxifen or radiotherapy in post-menopausal women.
Eur J Surg Oncol. 1996 Feb;22(1):34-7. doi: 10.1016/s0748-7983(96)91352-9.
8
Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.晚期乳腺癌治疗反应评估：瑞士日内瓦国际抗癌联盟临床肿瘤学项目。
Cancer. 1977 Mar;39(3):1289-94. doi: 10.1002/1097-0142(197703)39:3<1289::aid-cncr2820390340>3.0.co;2-f.
Zotero 插件